<!DOCTYPE html>
<html lang="en">
<head>
  
  
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
    
    <link rel="canonical" href="https://postssrisyndrome.github.io/postssrisyndrome/news/2018-12-21-ema-interroga-le-case-farmaceutiche-di-ssri-e-snri/">
    <link rel="shortcut icon" href="../../img/favicon.ico">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <title>L’Agenzia Europea per i Medicinali (EMA) interroga le case farmaceutiche di SSRI e SNRI - Post-SSRI Syndrome</title>
    <link href="../../css/bootstrap-3.3.7.min.css" rel="stylesheet">
    <link href="../../css/font-awesome-4.7.0.css" rel="stylesheet">
    <link href="../../css/base.css" rel="stylesheet">
    <link rel="stylesheet" href="../../css/highlight.css">
    <link href="../../css/extra.css" rel="stylesheet">
    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <script src="../../js/jquery-3.2.1.min.js"></script>
    <script src="../../js/bootstrap-3.3.7.min.js"></script>
    <script src="../../js/highlight.pack.js"></script>
    
    <base target="_top">
    <script>
      var base_url = '../..';
      var is_top_frame = false;
        
        var pageToc = [
          {title: "L\u2019Agenzia Europea per i Medicinali (EMA) interroga le case farmaceutiche di SSRI e SNRI", url: "#_top", children: [
          ]},
        ];

    </script>
    <script src="../../js/base.js"></script> 
</head>

<body>
<script>
if (is_top_frame) { $('body').addClass('wm-top-page'); }
</script>



<div class="container-fluid wm-page-content">
  <a name="_top"></a>
    

    

    <h1 id="lagenzia-europea-per-i-medicinali-ema-interroga-le-case-farmaceutiche-di-ssri-e-snri">L’Agenzia Europea per i Medicinali (EMA) interroga le case farmaceutiche di SSRI e SNRI</h1>
<p>Data: 21 Dicembre 2018</p>
<p>Nell’ambito della seduta PRAC (Pharmacovigilance Risk Assessment Committee) del 29-31 ottobre 2018, l’Agenzia Europea per i Medicinali (EMA – European Medicines Agency) ha richiesto alle case farmaceutiche di SSRI e SNRI chiarimenti approfonditi rispetto alle Disfunzioni sessuali persistenti in seguito alla sospensione del farmaco, da presentare all’EMA entro 60 giorni.</p>
<p>Il verbale è consultabile al seguente link (pag. 15-16): <a href="https://www.ema.europa.eu/documents/minutes/minutes-prac-meeting-29-31-october-2018_en.pdf" title="https://www.ema.europa.eu/documents/minutes/minutes-prac-meeting-29-31-october-2018_en.pdf">https://www.ema.europa.eu/documents/minutes/minutes-prac-meeting-29-31-october-2018_en.pdf</a></p>
<p><img alt="" src="../../img/screenshot-27.png" /></p>
<p><img alt="" src="../../img/screenshot-28.png" /></p>

  <br>
    

    <br>
</div>

<footer class="container-fluid wm-page-content">
  <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a> using <a href="https://github.com/gristlabs/mkdocs-windmill">Windmill</a> theme by Grist Labs.</p>
</footer>

</body>
</html>